CalciMedica, Inc. — Form SCHEDULE 13D/A
Filed August 21, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
Bering Partners II GP, L.L.C. filed an amended Schedule 13D/A regarding CalciMedica, Inc. on August 21, 2026. The filing does not disclose specific share counts, percentage ownership, or dollar amounts in the excerpt provided. Without access to the full document content, the nature and materiality of the amendment cannot be determined from the metadata alone.
Why this rating
Amendment to existing disclosure; metadata only lacks substantive ownership/transaction details needed to assess materiality relative to $15.7M market cap.
See more from August 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.